B cell depletion by Rituximab severely reduces immunoglobulin levels in patients with ANCA-associated vasculitis previously treated with cyclophosphamide.

An abstract of the conference paper "B cell depletion by Rituximab severely reduces immunoglobulin levels in patients with ANCA-associated vasculitis previously treated with cyclophosphamide," by several researchers including, Jens Thiel, Reinhard E. Voll, and Nils Venhoff is presented.